Geneos Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$502K Sell
5,754
-6,936
-55% -$605K 0.01% 706
2025
Q1
$867K Buy
12,690
+6,496
+105% +$444K 0.01% 711
2024
Q4
$482K Sell
6,194
-165
-3% -$12.8K 0.02% 603
2024
Q3
$426K Buy
6,359
+421
+7% +$28.2K 0.02% 597
2024
Q2
$673K Sell
5,938
-88
-1% -$9.98K 0.03% 427
2024
Q1
$836K Sell
6,026
-33
-0.5% -$4.58K 0.04% 384
2023
Q4
$752K Sell
6,059
-359
-6% -$44.5K 0.04% 383
2023
Q3
$599K Sell
6,418
-960
-13% -$89.6K 0.03% 427
2023
Q2
$948K Buy
7,378
+1,233
+20% +$158K 0.05% 324
2023
Q1
$714K Sell
6,145
-1,334
-18% -$155K 0.04% 368
2022
Q4
$847K Sell
7,479
-657
-8% -$74.4K 0.05% 303
2022
Q3
$655K Buy
8,136
+207
+3% +$16.7K 0.05% 333
2022
Q2
$615K Sell
7,929
-191
-2% -$14.8K 0.03% 445
2022
Q1
$1.04M Sell
8,120
-2,720
-25% -$348K 0.04% 344
2021
Q4
$1.46M Sell
10,840
-104
-1% -$14K 0.06% 307
2021
Q3
$1.5M Buy
10,944
+368
+3% +$50.6K 0.06% 296
2021
Q2
$1.14M Buy
10,576
+5,632
+114% +$608K 0.04% 330
2021
Q1
$477K Sell
4,944
-120
-2% -$11.6K 0.01% 648
2020
Q4
$417K Buy
5,064
+440
+10% +$36.2K 0.02% 586
2020
Q3
$465K Sell
4,624
-260
-5% -$26.1K 0.02% 450
2020
Q2
$467K Sell
4,884
-160
-3% -$15.3K 0.03% 426
2020
Q1
$331K Buy
5,044
+360
+8% +$23.6K 0.02% 470
2019
Q4
$255K Sell
4,684
-400
-8% -$21.8K 0.01% 604
2019
Q3
$188K Hold
5,084
0.01% 681
2019
Q2
$190K Hold
5,084
0.01% 686
2019
Q1
$151K Sell
5,084
-64
-1% -$1.9K 0.01% 733
2018
Q4
$152K Buy
5,148
+400
+8% +$11.8K 0.01% 686
2018
Q3
$169K Sell
4,748
-648
-12% -$23.1K 0.01% 701
2018
Q2
$128K Sell
5,396
-2,000
-27% -$47.4K 0.01% 706
2018
Q1
$137K Buy
7,396
+1,100
+17% +$20.4K 0.01% 648
2017
Q4
$90K Hold
6,296
0.01% 779
2017
Q3
$77K Hold
6,296
0.01% 788
2017
Q2
$115K Sell
6,296
-44
-0.7% -$804 0.01% 644
2017
Q1
$134K Buy
6,340
+6,092
+2,456% +$129K 0.01% 578
2016
Q4
$3K Buy
248
+96
+63% +$1.16K ﹤0.01% 1753
2016
Q3
$3K Buy
+152
New +$3K ﹤0.01% 1686